Abstract

Novo Actrapid (Neutral insulin injection-DFE), Nuso (neutral soluble insulin-British Insulin Manufacturers) and Novo Rapitard (Biphasic insulin injection-DFE) have recently become available for clinical use after protracted experiments on the solubility of highly purified insulins at various pH levels.^{1 2}